547 related articles for article (PubMed ID: 30138941)
1. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
2. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia.
Fattori V; Hohmann MSN; Rossaneis AC; Manchope MF; Alves-Filho JC; Cunha TM; Cunha FQ; Verri WA
Expert Opin Ther Targets; 2017 Dec; 21(12):1141-1152. PubMed ID: 29076792
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
Chen WY; Li LC; Yang JL
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
5. IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.
Du LX; Wang YQ; Hua GQ; Mi WL
Neuroscience; 2018 Jan; 369():222-230. PubMed ID: 29175156
[TBL] [Abstract][Full Text] [Related]
6. Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
Abd Rachman Isnadi MF; Chin VK; Abd Majid R; Lee TY; Atmadini Abdullah M; Bello Omenesa R; Osamah Ibraheem Z; Basir R
Mediators Inflamm; 2018; 2018():5346413. PubMed ID: 29507527
[TBL] [Abstract][Full Text] [Related]
7. Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury.
Chen WY; Li LC; Wu YH; Yang JL; Tzeng HT
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102434
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
9. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
Chan BCL; Lam CWK; Tam LS; Wong CK
Front Immunol; 2019; 10():364. PubMed ID: 30886621
[TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 axis in autoimmune disease.
Shakerian L; Kolahdooz H; Garousi M; Keyvani V; Kamal Kheder R; Abdulsattar Faraj T; Yazdanpanah E; Esmaeili SA
Cytokine; 2022 Oct; 158():156015. PubMed ID: 36041312
[TBL] [Abstract][Full Text] [Related]
11. IL-33/ST2 Axis Plays a Protective Effect in
Kuo CF; Chen WY; Yu HH; Tsai YH; Chang YC; Chang CP; Tsao N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638904
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
13. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33: increasing role in dermatological conditions.
Balato A; Raimondo A; Balato N; Ayala F; Lembo S
Arch Dermatol Res; 2016 Jul; 308(5):287-96. PubMed ID: 26969580
[TBL] [Abstract][Full Text] [Related]
15. IL-33/ST2 Axis in Organ Fibrosis.
Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
Front Immunol; 2018; 9():2432. PubMed ID: 30405626
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J; Kim S; Lin PC
J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
[TBL] [Abstract][Full Text] [Related]
17. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
19. The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?
Liu X; Xiao Y; Pan Y; Li H; Zheng SG; Su W
Cytokine Growth Factor Rev; 2019 Dec; 50():60-74. PubMed ID: 31085085
[TBL] [Abstract][Full Text] [Related]
20. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
